Patient | Gleason score | PSA (ng/ml) | Roach formula risk (%) | Primary staging (CT = 1, MRI = 2, Choline-PET = 3) | cTNM without PSMA-PET | cTNM including PSMA-PET | ||||
---|---|---|---|---|---|---|---|---|---|---|
T | N | M | T | N | M | |||||
1 | 6 | 19.1 | 13 | 1, 2, 3 | 1c | 1 | 0 | 1c | 0 | 0 |
2 | 7 | 8.5 | 16 | 1,2 | 3a | 0 | 0 | 3b | 0 | 0 |
3 | 8 | 9.6 | 26 | 1,2 | 2c | X | 0 | 2c | 1 | 0 |
4 | 6 | 39.6 | 26 | 1,2 | 3b | 0 | 0 | 3b | 1 | 0 |
5 | 9 | 34.2 | 53 | 1 | 1c | 0 | 0 | 2b | 0 | 0 |
6 | 6 | 8.2 | 6 | 1,2 | 2c | 0 | 0 | 2c | 0 | 0 |
7 | 7 | 36 | 34 | 1,2 | 3a | 0 | 0 | 3a | 1 | 1 a |
8 | 6 | 10.8 | 7 | 1 | 1c | 0 | 0 | 2a | 0 | 0 |
9 | 7 | 23 | 25 | 1,2 | 3b | 0 | 0 | 3b | 0 | 0 |
10 | 8 | 9.4 | 26 | 1,2,3 | 2c | 1 | 0 | 2c | 0 | 0 |
11 | 8 | 13.5 | 29 | 1 | 2b | 0 | 0 | 3b | 0 | 0 |
12 | 7 | 8.7 | 16 | 1,2 | 1c | 0 | 0 | 2a | 0 | 0 |
13 | 6 | 63.9 | 43 | 1 | 1c | 0 | 0 | 2c | 0 | 0 |
14 | 9 | 9.6 | 36 | 1,2 | 1c | 0 | 0 | 2c | 0 | 0 |
15 | 8 | 23 | 35 | 1, 2 | 1c | X | X | 2c | 1 | Xb |